Literature DB >> 33514850

Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage.

Amina Ait-Ammar1,2,3, Maxime Bellefroid3, Fadoua Daouad1, Valérie Martinelli4, Jeanne Van Assche1, Clémentine Wallet1, Anthony Rodari3, Marco De Rovere1, Birthe Fahrenkrog4, Christian Schwartz1, Carine Van Lint5, Virginie Gautier6, Olivier Rohr7.   

Abstract

HIV-1 latency generates reservoirs that prevent viral eradication by the current therapies. To find strategies toward an HIV cure, detailed understandings of the molecular mechanisms underlying establishment and persistence of the reservoirs are needed. The cellular transcription factor KAP1 is known as a potent repressor of gene transcription. Here we report that KAP1 represses HIV-1 gene expression in myeloid cells including microglial cells, the major reservoir of the central nervous system. Mechanistically, KAP1 interacts and colocalizes with the viral transactivator Tat to promote its degradation via the proteasome pathway and repress HIV-1 gene expression. In myeloid models of latent HIV-1 infection, the depletion of KAP1 increased viral gene elongation and reactivated HIV-1 expression. Bound to the latent HIV-1 promoter, KAP1 associates and cooperates with CTIP2, a key epigenetic silencer of HIV-1 expression in microglial cells. In addition, Tat and CTIP2 compete for KAP1 binding suggesting a dynamic modulation of the KAP1 cellular partners upon HIV-1 infection. Altogether, our results suggest that KAP1 contributes to the establishment and the persistence of HIV-1 latency in myeloid cells.

Entities:  

Year:  2021        PMID: 33514850     DOI: 10.1038/s41598-021-82164-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  62 in total

1.  Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.

Authors:  Céline Marban; Stella Suzanne; Franck Dequiedt; Stéphane de Walque; Laetitia Redel; Carine Van Lint; Dominique Aunis; Olivier Rohr
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 2.  The many lives of CTIP2: from AIDS to cancer and cardiac hypertrophy.

Authors:  Valentin Le Douce; Thomas Cherrier; Raphael Riclet; Olivier Rohr; Christian Schwartz
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

Review 3.  A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.

Authors:  Janice E Clements; Lucio Gama; David R Graham; Joseph L Mankowski; M C Zink
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

4.  Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.

Authors:  Benjamin B Gelman; Joshua G Lisinicchia; Susan Morgello; Eliezer Masliah; Deborah Commins; Cristian L Achim; Howard S Fox; Dennis L Kolson; Igor Grant; Elyse Singer; Constantin T Yiannoutsos; Seth Sherman; Gary Gensler; David J Moore; Tiansheng Chen; Vicki M Soukup
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

5.  LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing.

Authors:  Valentin Le Douce; Laurence Colin; Laetitia Redel; Thomas Cherrier; Georges Herbein; Dominique Aunis; Olivier Rohr; Carine Van Lint; Christian Schwartz
Journal:  Nucleic Acids Res       Date:  2011-11-08       Impact factor: 16.971

Review 6.  HIV-1 latency in monocytes/macrophages.

Authors:  Amit Kumar; Wasim Abbas; Georges Herbein
Journal:  Viruses       Date:  2014-04-22       Impact factor: 5.048

7.  HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1.

Authors:  Valentin Le Douce; Faezeh Forouzanfar; Sebastian Eilebrecht; Benoit Van Driessche; Amina Ait-Ammar; Roxane Verdikt; Yoshihito Kurashige; Céline Marban; Virginie Gautier; Ermanno Candolfi; Arndt G Benecke; Carine Van Lint; Olivier Rohr; Christian Schwartz
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

Review 8.  Are T cells the only HIV-1 reservoir?

Authors:  Abraham Joseph Kandathil; Sho Sugawara; Ashwin Balagopal
Journal:  Retrovirology       Date:  2016-12-20       Impact factor: 4.602

9.  HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.

Authors:  Jenna B Honeycutt; William O Thayer; Caroline E Baker; Ruy M Ribeiro; Steven M Lada; Youfang Cao; Rachel A Cleary; Michael G Hudgens; Douglas D Richman; J Victor Garcia
Journal:  Nat Med       Date:  2017-04-17       Impact factor: 53.440

10.  HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency.

Authors:  George N Llewellyn; David Alvarez-Carbonell; Morgan Chateau; Jonathan Karn; Paula M Cannon
Journal:  J Neurovirol       Date:  2017-12-18       Impact factor: 2.643

View more
  9 in total

Review 1.  Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.

Authors:  Tom Sidwell; Ellen V Rothenberg
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

2.  Trim28 acts as restriction factor of prototype foamy virus replication by modulating H3K9me3 marks and destabilizing the viral transactivator Tas.

Authors:  Peipei Yuan; Jun Yan; Shuang Wang; Yang Guo; Xueyan Xi; Song Han; Jun Yin; Biwen Peng; Xiaohua He; Jochen Bodem; Wanhong Liu
Journal:  Retrovirology       Date:  2021-12-13       Impact factor: 4.602

Review 3.  KAP1/TRIM28: Transcriptional Activator and/or Repressor of Viral and Cellular Programs?

Authors:  Keyera Randolph; Usman Hyder; Iván D'Orso
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 6.073

4.  Novel role of UHRF1 in the epigenetic repression of the latent HIV-1.

Authors:  Roxane Verdikt; Maryam Bendoumou; Sophie Bouchat; Lorena Nestola; Alexander O Pasternak; Gilles Darcis; Véronique Avettand-Fenoel; Caroline Vanhulle; Amina Aït-Ammar; Marion Santangelo; Estelle Plant; Valentin Le Douce; Nadège Delacourt; Aurelija Cicilionytė; Coca Necsoi; Francis Corazza; Caroline Pereira Bittencourt Passaes; Christian Schwartz; Martin Bizet; François Fuks; Asier Sáez-Cirión; Christine Rouzioux; Stéphane De Wit; Ben Berkhout; Virginie Gautier; Olivier Rohr; Carine Van Lint
Journal:  EBioMedicine       Date:  2022-04-14       Impact factor: 11.205

5.  Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models.

Authors:  Lendel Correia da Costa; Larissa Maciel Bomfim; Uilla Victoria Torres Dittz; Camila de Almeida Velozo; Rodrigo Delvecchio da Cunha; Amilcar Tanuri
Journal:  Retrovirology       Date:  2022-06-22       Impact factor: 3.768

Review 6.  Tuning Rex rules HTLV-1 pathogenesis.

Authors:  Kazumi Nakano; Toshiki Watanabe
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

Review 7.  Epigenetic Mechanisms of HIV-1 Persistence.

Authors:  Roxane Verdikt; Olivier Hernalsteens; Carine Van Lint
Journal:  Vaccines (Basel)       Date:  2021-05-17

Review 8.  Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?

Authors:  Thanarat Salahong; Christian Schwartz; Rungroch Sungthong
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

Review 9.  Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system.

Authors:  Fergan Imbert; Dianne Langford
Journal:  J Neurovirol       Date:  2021-08-03       Impact factor: 2.643

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.